TARDBP and early-onset autosomal dominant Alzheimer disease: Beyond FTLD, TMEM106B has been implicated in TDP-43 pathology in Alzheimer disease (AD),18 cognition in Parkinson disease (PD),17 and ALS, though with conflicting findings in directionality of effects in ALS.19,20